UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | I | J | K | M | N | O | P | R | S | T | U | V | W
Number of items: 133.

A

Ataman, OU; Bentzen, SM; Saunders, MI; Dische, S; (2001) Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced nonsmall-cell lung cancer: A competing risks analysis. British Journal of Cancer , 85 (8) 1113 - 1118.

B

Bahadur, G; Whelan, J; Davies, MC; Ralph, D; (2001) Cancer patients, gametes, gonadal tissue, and the UK legal status. Reproductive Biomedicine Online , 2 (1) 8 - 10.

Bahadur, G; Whelan, J; Ralph, D; Hindmarsh, P; (2001) Adolescent cancer patients sperm storage, consent and emotion. Human Reproduction , 16 (11) 2474 - ?.

Bahadur, G; Whelan, J; Ralph, D; Hindmarsh, P; (2001) Gaining consent to freeze sperm from adolescents with cancer: legal, ethical and practical aspects. Human Reproduction , 16 (1) 188 - 193.

BBC, 6ON; (2001) Thalidomide trial in lung cancer. UNSPECIFIED

BBC, N; (2001) 'My hope for Thalidomide cure'. UNSPECIFIED

BBC, NATIBFW; BBC, OTN; BBC, N2B; (2001) Thalidomide is cancer weapon. UNSPECIFIED

BBC, R4IBRH; (2001) UNSPECIFIED UNSPECIFIED

Bentzen, SA; Saunders, MI; Dische, S; Bond, SJ; (2001) Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiotherapy And Oncology , 60 (2) 123 - 135.

Bentzen, SM; Saunders, MI; Dische, S; Parmar, MKB; (2001) Accelerated radiotherapy vs. chemoradiation in non-small cell lung cancer: Quantifying the hazards [2]. Radiotherapy and Oncology , 58 (1) 91 - 92.

Boddy, AV; Griffin, MJ; Sludden, J; Thomas, HD; Fishwick, K; Wright, JG; ... Calvert, AH; + view all (2001) Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer. CANCER CHEMOTH PHARM , 48 (1) 15 - 21.

Bowman, KJ; Newell, DR; Calvert, AH; Curtin, NJ; (2001) Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. BRIT J CANCER , 84 (1) 106 - 112. 10.1054/bjoc.2000.1555.

Bownes, PJ; Hoskin, PJ; Ostler, P; (2001) Quality assurance for fractionated highdose rate afterloading brachytherapy of prostate cancer. In: Clinical Oncology. (pp. S7 - ?).

Bownes, PJ; Ostler, P; Hoskin, PJ; (2001) The effect of catheter movement on implant quality for fractionated high dose rate afterloading brachytherapy of prostate cancer. In: Radiotherapy And Oncology. (pp. S30 - ?).

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emett, J; Wong, WL; (2001) Evaluation of clinical complete response to neoadjuvant chemotherapy in primary breast cancer using (F-18)- fluorodeoxyglucose positron emission tomography. British Journal of Cancer , 85 50 - 50.

Burcombe, RJ; Makris, A; Richman, PI; Pittam, M; Daley, F; Nobe, S; Wilson, GD; (2001) Evaluation of ER, PgR, HER2 and Ki67 as predictors of response to neoadjuvant chemotherapy for operable breast cancer. British Journal of Cancer , 85 50 - 50.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, P; Meyer, T; ... Hilson, AJW; + view all (2001) Use of radiolanreotice to treat somatostatin receptor positive tumours. European Journal of Nuclear Medicine , 28 (8) S480 - ?.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, PL; Meyer, T; ... Hilson, AJW; + view all (2001) Treating somatostatin receptor positive tumours with radiolanreotide. European Journal of Nuclear Medicine , 28 (8) OS253 - ?.

C

Cerone, MA; Londono-Vallejo, JA; Bacchetti, S; (2001) Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet , 10 (18) 1945 - 1952.

Cooke, SP; Boxer, GM; Lawrence, L; Pedley, RB; Spencer, DIR; Begent, RHJ; Chester, KA; (2001) A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex. CANCER RES , 61 (9) 3653 - 3659.

Craddock, C; Spanswick, V; Mahendra, P; Sekhar, M; Hartley, JA; (2001) Repair of DNA interstarand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. In: British Journal of Haematology. (pp. 41 - ?).

Curtin, N; Barton, S; Batey, M; Calabrese, C; Calvert, H; Durkacz, B; ... Webber, S; + view all (2001) Anti-cancer chemosensitization in vitro and in vivo by a novel potent poly(ADP-ribose) polymerase (PARP1) inhibitor, TBI-361. CLIN CANCER RES , 7 (11) 3740S - 3740S.

D

Daily, S; (2001) Hell drug for cancer.

David, D; (2001) Thalidomide in trials to treat lung cancer. Daily Telegraph 4 - ?.

David, F; (2001) Birth defects drug may return. Financial Times

Dickson, J; Bownes, P; Ostler, P; Hoskin, PJ; (2001) Combined external beam and brachytherapy boost for localised prostate cancer: A report of procedural complications and acute radiation toxicity. In: British Journal of Cancer. (pp. 89 - 89).

F

Farnie, G; Atkins, H; Calvert, AH; Curtin, NJ; Golding, BT; Griffin, RJ; ... Lunec, J; + view all (2001) Inhibiting the MDM2-p53 interaction using low molecular weight compounds. BRIT J CANCER , 85 81 - 81.

Flynn, AA; Boxer, GM; Begent, RHJ; Pedley, RB; (2001) Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images. CANCER IMMUNOL IMMUN , 50 (2) 77 - 81.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, R; Begent, RH; (2001) A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor. Radiat Res , 156 (1) 28 - 35.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, R; Begent, RHJ; (2001) A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor. RADIAT RES , 156 (1) 28 - 35.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, RAB; R, HJ; (2001) A mouse model for calculating the absorbed beta dose, from 131I and 90Y labelled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumour. Radiation Research , 156 28 - 35.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Begent, RH; (2001) Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images. Cancer Biother Radiopharm , 16 (5) 391 - 400. 10.1089/108497801753354294.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Begent, RHJ; (2001) Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images. CANCER BIOTHER RADIO , 16 (5) 391 - 400.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; ... Begent, RHJ; + view all (2001) Effectiveness of radiolabelled antibodies for radio- immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation. International Journal of Radiation Biology , 77 (4) 507 - 517.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; ... Begent, RHJ; + view all (2001) Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation. INT J RADIAT BIOL , 77 (4) 507 - 517.

G

Gary, J; (2001) Thalidomide brilliant at beating Lung Cancer. The Mirror 24 - ?.

Goodchild, K; Hill, SA; Sibtain, A; Chaplin, DJ; Makris, A; (2001) Assessment of microregional blood flow in human breast carcinomas after administration of anthracycline chemotherapy. British Journal of Cancer , 85 48 - 48.

Green, AJ; Baig, S; Begent, RHJ; CRC Targeting & Imaging Grp,; (2001) Use of gadolinium-153 transmission attenuation maps for quantitative I-131SPECT with dual window scatter correction. EUR J NUCL MED , 28 (8) 1109 - 1109.

Green, AJ; Baig, S; Francis, RJ; Begent, RHJ; CRC Targeting & Imaging Grp,; (2001) Semi quantitative analysis of F18-FDG imaging using a hybrid camera for the assessment of tumour response to therapy. EUR J NUCL MED , 28 (8) 1109 - 1109.

Green, AJ; Johnson, CJ; Adamson, KL; Begent, RHJ; (2001) Mathematical model of antibody targeting: important parameters defined using clinical data. PHYS MED BIOL , 46 (6) 1679 - 1693.

Gregson, SJ; Howard, PW; Hartley, JA; Brooks, NA; Adams, LJ; Jenkins, TC; ... Thurston, DE; + view all (2001) Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J MED CHEM , 44 (5) 737 - 748. 10.1021/jm001064n.

Guiducci, C; Cerone, MA; Bacchetti, S; (2001) Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene , 20 (6) 714 - 725. 10.1038/sj.onc.1204145.

H

Hartley, JA; (2001) Alkylating agents. In: Souhami, RL and Tannock, IF and Hohenberger, P and Horiot, JC, (eds.) Oxford Textbook of Oncology. (639 - 654).

Hartley, JC; Kaye, S; Stevenson, S; Bennett, J; Ridgway, G; (2001) PCR detection and molecular identification of Chlamydiaceae species. Journal of Clinical Microbiology , 39 (9) 3072 - 3079.

Hoskin, PJ; Chow, EL; Wu, J; Coia, L; (2001) Uncertainties in the measurement of metastatic bone pain. In: Clinical Oncology. (pp. S5 - ?).

Hoskin, PJ; Dickson, J; (2001) Clincal uncertainties in the use of radical nodal irradiation in Hodgkins disease. In: Clinical Oncology. (pp. S3 - ?).

Hoskin, PJ; Dickson, J; (2001) Survival and morbidity after post operative vaginal va. In: British Journal of Cancer. (pp. 90 - ?).

Hoskin, PJ; Yarnold, JR; Roos, DR; Bentzen, S; (2001) Radiotherapy for bone metastases. Clinical Oncology , 13 (2) 88 - 90.

Howie, AJ; Ferreira, MAS; Adu, D; (2001) Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrology Dialysis Transplantation , 16 (6) 1163 - 1169.

Hughes, AN; Lind, M; Azzabi, A; Todd, R; Plummer, R; Margetts, J; ... Calvert, H; + view all (2001) A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate). BREAST CANCER RES TR , 69 (3) 286 - 286.

I

ITN, NLSIBRB; (2001) Thalidomide: new use for drug. UNSPECIFIED

J

Jacqui Thornton, MR; (2001) Can the drug which did this cure cancer? Thalidomide shrinks tumours. The Sun 39 - ?.

James, M; (2001) Thalidomide may fight cancer. Independent

James, M; (2001) Thalidomide may fight cancer. Tablets that caused horrific birth defects thought to help shrink tumours. The Guardian 2 - ?.

Jennings, SA; Toth, JL; Roller, SG; Brooks, N; O'Hare, C; Kiakos, K; ... Lee, M; + view all (2001) Efficient synthesis of (+/-)-seco-cyclopropaneindoline analogs of CC-1065. HETEROCYCL COMMUN , 7 (1) 7 - 16.

Jenny, H; (2001) Thalidomide therapy. Disgraced drug offers hope in lung cancer fight. Daily Mail 39 - ?.

Jeremy, L; (2001) Thalidomide is used to treat lung cancer. The Independent

Jo, H; (2001) Thalidomide hope for Cancer. GP Magazine 33 - ?.

John, C; (2001) Thalidomide for cancer victims. Daily Express

K

Kiakos, K; Brooks, N; Hartley, JA; Toth, J; Lee, M; (2001) Design, synthesis,cytotoxicity and sequence specificity of N-methylpyrrole C-and N-terminus linked seco-cyclopropylindole hybrid molecules. In: Proceeding of American Association for Cancer Research. (pp. 1374 - ?).

Kiakos, K; Brooks, N; McHugh, PJ; Loward, T; Lee, M; Hartley, JA; (2001) Repair of seqence specific adenine-N3 alkylations in the minor groove of DNA. In: Proceeding of American Association for Cancer Research. (pp. 3737 - ?).

M

Mainwaring, PN; Cunningham, D; Gregory, W; Hoskin, P; Hancock, B; Norton, AJ; ... Linch, D; + view all (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 15 (97) 2991 - 2997.

Makris, A; Burcombe, RJ; Cladd, H; Smith, JM; Makris, M; (2001) Raised plasma homocysteine levels in women with metastatic breast cancer. British Journal of Cancer , 85 26 - 26.

Maxwell-Armstrong, CA; Durrant, LG; Buckley, TJD; Scholefield, JH; Robins, RA; Fielding, K; ... Hardcastle, JD; + view all (2001) Randomized double-blind phase II survival study comparing immunization with the anti idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. BRIT J CANCER , 84 (11) 1443 - 1446.

McGurk, CJ; McHugh, PJ; Tilby, MJ; Grimaldi, KA; Hartley, JA; (2001) Measurement of covalent drug-DNA interactions at the nucleotide level in cells at pharmacologically relevant doses. METHOD ENZYMOL , 340 358 - 376.

McHugh, PJ; Spanswick, VJ; Hartley, JA; (2001) Repair of DNA interstrand crosslinks molecular mechanisms and clinical relevance. The Lancet Oncology , 2 483 - 490.

McHugh, PJ; Spanswick, VJ; Hartley, JA; (2001) Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol , 2 (8) 483 - 490. 10.1016/S1470-2045(01)00454-5.

Meyer, T; Cole, LA; Richman, PI; Mitchell, HD; Myers, J; Rustin, GJ; (2001) High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men. Clin Oncol (R Coll Radiol) , 13 (4) 301 - 303.

Meyer, T; Davidson, B; Hochhauser, D; Dhillon, P; Begent, R; (2001) Fibrolamellar Carcinoma: a Strategy for Management. In: Journal of Clinical Oncology. (pp. 2311 - ?).

Meyer, T; Nelstrop, AE; Mahmoudi, M; Rustin, GJ; (2001) Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer. Ann Oncol , 12 (12) 1705 - 1709.

Miles, DW; Smith, IE; Coleman, RE; Calvert, AH; Lind, MJ; (2001) A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer. EUR J CANCER , 37 (11) 1366 - 1371.

N

Nathan, PD; Walker, D; Bridle, H; Ross, A; Stevenson, A; Lee, SM; ... Gore, M; + view all (2001) A phase II study investigating the use of thalidomide in conjunction with interferon-alpha in patients with metastatic renal cell carcinoma. In: (Proceedings) 2001 ASCO Annual Meeting/37th Annual Meeting, San Francisco, California.. (pp. 265a - ?). Proceedings of the American Society of Clinical Oncology

Ndisang, D; Budhram-Mahadeo, V; Pedley, RBAL; D, S; (2001) The Brn-3a transcription factor plays a key role in regulating the growth of cervical cells in vivo. Oncogene , 20 4899 - 4903.

Nigel, H; (2001) Thalidomide returns in lung cancer battle. The Times 12 - ?.

Nutting, C; Short, S; (2001) Where now with training in clinical oncology? Clinical Oncology , 13 4 - 5.

O

Okkenhaug, K; Vanhaesebroeck, B; (2001) New responsibilities for the PI3K regulatory subunit p85 alpha. Sci STKE , 2001 (65) pe1 - ?. 10.1126/stke.2001.65.pe1.

Osborne, M; Makris, A; Hoskin, PJ; Lowe, J; Emmott, J; Wong, WL; (2001) The role of FDG whole body positron emission tomography in metastatic carcinoma of unknown primary site. British Journal of Cancer , 85 90 - 90.

Osborne, M; Shah, N; Hoskin, PJ; Powell, MG; Anthony-Pillau, R; Glynne-Jones, R; Makris, A; (2001) Low dose folinic acid with infusional and bolus 5fluorouracil in advanced colorectal carcinoma. British Journal of Cancer , 85 44 - 44.

Osborne, ME; Brown, RSD; Hoskin, PJ; (2001) Interaction of bisphosphonates with calcitonin in monitoring medullary carcinoma of the thyroid. Clinical Oncology , 13 (5) 370 - 371.

P

Parkinson, MC; Harland, SJ; Harnden, P; Sandison, A; (2001) The role of the histopathologist in the management of testicular germ cell tumour in adults. HISTOPATHOLOGY , 38 (3) 183 - 194.

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, G; Boden, R; ... Begent, RHJ; + view all (2001) Overcoming the problem of tumour heterogeneity by combined, regios-specific therapies. In: Proceeding of American Association for Cancer Research. (pp. 871 - ?).

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, GM; Boden, R; ... and Begent, RHJ; + view all (2001) Overcoming the problem of tumour heterogeneity by combined, region-specific therapies. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 871 - ?).

Pedley, RB; Hill, SA; Boxer, GM; Flynn, AA; Boden, R; Watson, R; ... Begent, RHJ; + view all (2001) Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate. CANCER RES , 61 (12) 4716 - 4722.

Pritchard, JK; Devine, T; Lewis, I; Whelan, J; Hale, J; Campbell, B; ... Durrant, LG; + view all (2001) Endogenous and induced immune responses to the 105AD7 anti-idiotypic vaccine in osteosarcoma patients following intensive chemotherapy. In: International Society of Paediatric Oncology, Brisbane Sept 2001 Med Ped Oncol 2001;37:203.

R

Rustin, GJ; Marples, M; Nelstrop, AE; Mahmoudi, M; Meyer, T; (2001) Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol , 19 (20) 4054 - 4057.

S

Saunders, MI; (2001) Programming of radiotherapy in the treatment of non-small-cell lung cancer- Away to advance care. The Lancet Oncology , 2 401 - 408.

Shah, N; Joiner, MC; Saunders, MI; (2001) An evaluation of human skin epidermal cells for hyper- radiosensitivity. British Journal of Cancer , 85 16 - 16.

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KA; Begent, RHJ; (2001) Immunogenicity of carboxypeptidase G2 (CPG2) enzyme in ADEPT. BRIT J CANCER , 85 98 - 98.

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KA; Begent, RHJ; (2001) Immunogenicity of carboxypeptidase G2 (CPG2) enzyme in ADEPT. In: British Journal of Cancer. (pp. 98 - 98).

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KAAB; R, HJ; (2001) Immunogenicity of carboxypeptidase G2(CPG2) enzyme in ADEPT. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 98 - ?).

Sharma, SK; Irwin, H; Pedley, RB; Bhatia, J; Dearling, J; Flynn, A; ... Begent, RHJ; + view all (2001) Biodistribution of I-123-labelled MFE-CP fusion protein in LS174T xenografted nude mice. BRIT J CANCER , 85 99 - 99.

Sharma, SK; Irwin, H; Pedley, RB; Bhatia, J; Dearling, J; Flynn, A; ... Begent, RHJ; + view all (2001) Biodistribution of I-123-labelled MFE-CP fusion protein in LS174T xenografted nude mice. British Journal of Cancer , 85 99 - 99.

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KA; Begent, RHJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: Proceeding of American Association for Cancer Research. (pp. 136 - ?).

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KAAB; R, HJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 136 - ?).

Short, S; (2001) Thalidomide as an anti-angiogenic agent in recurrent gliomas. Journal of Neuro-Oncology , 51 41 - 55.

Short, SC; Brada, M; (2001) The treatment of malignant celebral tumours. Hospital Medicine , 61 (11) 772 - 777.

Short, SC; Kelly, J; mayes, CR; Woodcock, M; Joiner, MC; (2001) Low-dose hypersensitivity after fractionated low-dose irradiation. International journal of radiation biology , 77 (6) 655 - 664.

Short, SC; Traish, D; Dowe, A; Hines, F; Gore, M; Brada, M; (2001) Thalidomide as an anti-angiogenic agent in relapsed gliomas. Journal of Neuro-Oncology , 51 (1) 41 - 45.

Sibtain, A; Wilson, GD; Hoskin, PJ; (2001) Tumour hypoxia and vascularity in lymphoma. British Journal of Cancer , 85 36 - 36.

Sierens, J; Hartley, JA; Campbell, MJ; Leathem, AJC; Woodside, JV; (2001) Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay. MUTAT RES-DNA REPAIR , 485 (2) 169 - 176.

Sky, NRTM; (2001) Thalidomide could be used to treat lung cancer. UNSPECIFIED

Smith, PG; Thomas, HD; Barlow, HC; Griffin, RJ; Golding, BT; Calvert, AH; ... Curtin, NJ; + view all (2001) In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity. CLIN CANCER RES , 7 (7) 2105 - 2113.

Smyth, J; Boneterre, ME; Schellens, J; Calvert, H; Greim, G; Wanders, J; ... EORTC Early Clin Studies Grp,; + view all (2001) Activity of the dolastatin analogue, LU103793, in malignant melanoma. ANN ONCOL , 12 (4) 509 - 511.

Spanswick, V; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hochhauser, D; Hartley, J; (2001) Repair of melphalan induced DNA interstrand crosslinks in patients who relapse after autologous stem cell transplantation for multiple myeloma. In: (pp. 3174 - ?).

T

Taylor, NJ; Baddeley, H; Goodchild, KA; Powell, MEB; Thoumine, M; Culver, LA; ... Griffiths, JR; + view all (2001) BOLD MRI of human tumor oxygenation during carbogen breathing. Journal of Magnetic Resonance Imaging , 14 (2) 156 - 163.

Timothy, AR; Girling, DJ; Saunders, MI; Macbeth, F; Hoskin, PJ; (2001) Radiotherapy for inoperable lung cancer. Clinical Oncology , 13 (2) 86 - 87.

Todd, R; Boddy, AV; Verrill, M; Sludden, J; Griffin, MJ; Elliott, S; ... Calvert, AH; + view all (2001) Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate. Clinical Cancer Research , 7 (11) 115 - ?.

Tolner, B; Greenberg, B; Hartley, J; Hochhauser, D; (2001) Effects of the DNA minor groove binding agent ecteinascidin (ET-743) on the topoisomerase II alpha promoter. Clinical Cancer Research , 7 (11) 703 - ?.

Tolner, B; Greenberg, B; Hartley, J; Hochhauser, D; (2001) Effects of the DNA minor groove binding agent ecteinascidin (ET-743) on the topoisomerase II alpha promoter. CLIN CANCER RES , 7 (11) 3795S - 3795S.

Tolner, B; Hartley, JA; Hochhauser, D; (2001) Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs. MOL PHARMACOL , 59 (4) 699 - 706.

U

UCL, N; (2001) Thalidomide to be used in cancer fight. 14 - ?.

UCL, NFP; (2001) 'Thalidomide tested against cancer'.

V

Vanhaesebroeck, B; Leevers, SJ; Ahmadi, K; Timms, J; Katso, R; Driscoll, PC; ... Waterfield, MD; + view all (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem , 70 535 - 602. 10.1146/annurev.biochem.70.1.535.

Venables, K; Winfield, E; Ariad, EGA; Hoskin, PJ; (2001) Dosimetric uncertainties in the delivery of breast radiotherapy. Clinical Oncology , 13 (2) S2 - ?.

Venables, K; Winfield, E; Deighton, A; Aird, E; Hoskin, P; (2001) A survey of radiotherapy quality control practice in the United Kingdom for the START trial. Radiotherapy And Oncology , 60 (3) 311 - 318.

Venables, K; Winfield, E; Deighton, A; Aird, E; Hoskin, P; (2001) The START Trial - measurements in semi-anatomical breast and chest wall phantoms. Physics in Medicine and Biology , 46 (7) 1937 - 1948.

von Schlippe, M; Fowler, CJ; Harland, SJ; (2001) Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis. BRIT J CANCER , 85 (6) 823 - 826. 10.1054/bjoc.2001.2006.

W

Walker, AE; Hall-Craggs, MA; Pringle, J; Whelan, JS; Witt, JD; Cobb, JP; (2001) MR-guided percutaneous biopsy of primary bone and soft tissue tumors. In: Radiological Society of North America, Chicago Oct 2001.

Wardman, P; Folkes, LK; Bentzen, SM; Stratford, MRL; Hoskin, PJ; Phillips, H; Jackson, S; (2001) Influence of plasma glutathione levels on radiation mucositis. International Journal of Radiation Oncology Biology Physics , 51 (2) 460 - 464.

Webley, SD; Francis, RJ; Pedley, RB; Sharma, SK; Begent, RHJ; Hartley, JA; Hochhauser, D; (2001) Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material. BRIT J CANCER , 84 (12) 1671 - 1676. 10.1054/bjoc.2001.1843.

Wendy, V; (2001) Thalidomide could treat lung cancer. Metro 9 - ?.

Whelan, JS; Cassoni, AM; Cobb, JP; (2001) Bone. In: Price, P and Sikora, K, (eds.) Treatment of Cancer. : London.

Whelan, JS; Driver, D; Brock, C; McTiernan, A; Hamilton, C; Michelagnoli, M; (2001) Hepatic veno-occlusive disease complicating high dose chemotherapy for Ewing’s sarcoma. In: International Society of Paediatric Oncology, Brisbane Sept 2001 Med Ped Oncol 2001;37:217.

Whelan, JS; Riley, V; (2001) Navigating in difficult waters: the care of teenagers with advanced cancer. In: International Society of Paediatric Oncology, Brisbane Sept 2001 Med Ped Oncol 2001;37:180.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; ... Mehta, AB; + view all (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 114 (3) 608 - 615.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; ... Mehta, AB; + view all (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. Br J Haematol , 114 (3) 608 - 615.

Wilson, E; Makris, A; Novell, IR; (2001) Implementation of the two week rule has little effect on diagnostic yield in colorectal cancer. In: European Journal of Cancer. (pp. S121 - ?).

Wilson, GD; Saunders, MI; Dische, S; Richman, PI; Daley, FM; Bentzen, SM; (2001) bcl-2 expression in head and neck cancer: An enigmatic prognostic marker. International Journal of Radiation Oncology Biology Physics , 49 (2) 435 - 441.

Winfield, E; Venables, K; Aird, E; Hoskin, PJ; (2001) Film dosimetry, at depth, of the matchplane between breast tangential fields and anterior supraclavicular fossa field. In: Radiotherapy And Oncology. (pp. S206 - ?).

Winfield, E; Venables, K; Aird, E; Hoskin, PJ; (2001) In vivo disimertry for patients in the START Trial. In: Radiotherapy And Oncology. (pp. S209 - ?).

Woll, PJ; Thatcher, N; Lomax, L; Hodgetts, J; Lee, SM; Burt, PA; ... Pettengell, R; + view all (2001) Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomised phase II trial in small cell lung cancer. Journal of Clinical Oncology , 19 (3) 712 - 719.

Wright, JG; Boddy, AV; Highley, M; Fenwick, J; McGill, A; Calvert, AH; (2001) Estimation of glomerular filtration rate in cancer patients. BRIT J CANCER , 84 (4) 452 - 459.

This list was generated on Sun Sep 21 03:26:25 2014 BST.